The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Nanoparticles in Targeted Cancer Therapy: Mesoporous Silica Nanoparticles Entering Preclinical Development Stage
Abstract
Nanotechnology may help overcome persisting limitations of current cancer treatment and thus contribute to the creation of more effective, safer and more affordable therapies. While some nanotechnology-based drug delivery systems are already being marketed and others are in clinical trial, most still remain in the preclinical development stage. Mesoporous silica nanoparticles have been highlighted as an interesting drug delivery platform, due to their flexibility and high drug load potential. Although numerous reports demonstrate sophisticated drug delivery mechanisms in vitro, the therapeutic benefit of these systems for in vivo applications have been under continuous debate. This has been due to nontranslatable conditions used in the in vitro studies, as well as contradictory conclusions drawn from preclinical (in vivo) studies. However, recent studies have indicated that the encouraging cellular studies could in fact be repeated also in vivo. Here, we report on these recent advances regarding therapeutic efficacy, targeting and safety issues related to the application of mesoporous silica nanoparticles in cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Kim, J., Kim, H. S., Lee, N., Kim, T., Kim, H., Yu, T., Song, I. C., Moon, W. K., & Hyeon, T. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200802469 · Cited by 1,220
Lu, J., Liong, M., Li, Z., Zink, J. I., & Tamanoi, F. (2010) · Small · doi:10.1002/smll.201000538 · Cited by 1,074
Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery
Vivero‐Escoto, J. L., Slowing, I. I., Trewyn, B. G., & Lin, V. S. ‐. (2010) · Small · doi:10.1002/smll.200901789 · Cited by 998
Bright and Stable Core−Shell Fluorescent Silica Nanoparticles
Ow, H., Larson, D. R., Srivastava, M., Baird, B. A., Webb, W. W., & Wiesner, U. (2005) · Nano Letters · doi:10.1021/nl0482478 · Cited by 932
Huang, X., Li, L., Liu, T., Hao, N., Liu, H., Chen, D., & Tang, F. (2011) · ACS Nano · doi:10.1021/nn200365a · Cited by 921
Lin, Y.-S., & Haynes, C. L. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910846q · Cited by 837
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
Libutti, S. K., Paciotti, G. F., Byrnes, A. A., Alexander, H. R., Gannon, W. E., Walker, M., Seidel, G. D., Yuldasheva, N., & Tamarkin, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0978 · Cited by 710
Lee, J. E., Lee, N., Kim, H., Kim, J., Choi, S. H., Kim, J. H., Kim, T., Song, I. C., Park, S. P., Moon, W. K., et al. (2010) · Journal of the American Chemical Society · doi:10.1021/ja905793q · Cited by 707
He, Q., & Shi, J. (2011) · Journal of Materials Chemistry · doi:10.1039/c0jm03851b · Cited by 691
He, Q., Zhang, Z., Gao, F., Li, Y., & Shi, J. (2011) · Small · doi:10.1002/smll.201001459 · Cited by 661
Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma
Benezra, M., Penate-Medina, O., Zanzonico, P. B., Schaer, D., Ow, H., Burns, A., DeStanchina, E., Longo, V., Herz, E., Iyer, S., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45600 · Cited by 645
Zhao, Y., Sun, X., Zhang, G., Trewyn, B. G., Slowing, I. I., & Lin, V. S.-Y. (2011) · ACS Nano · doi:10.1021/nn103077k · Cited by 572
Rosenholm, J. M., Sahlgren, C., & Lindén, M. (2010) · Nanoscale · doi:10.1039/c0nr00156b · Cited by 572
Self-citationThe biocompatibility of mesoporous silicates
Hudson, S. P., Padera, R. F., Langer, R., & Kohane, D. S. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.07.007 · Cited by 538
Mesoporous Silica Nanoparticles for Reducing Hemolytic Activity Towards Mammalian Red Blood Cells
Slowing, I. I., Wu, C., Vivero‐Escoto, J. L., & Lin, V. S. ‐. (2009) · Small · doi:10.1002/smll.200800926 · Cited by 527
Meng, H., Xue, M., Xia, T., Ji, Z., Tarn, D. Y., Zink, J. I., & Nel, A. E. (2011) · ACS Nano · doi:10.1021/nn200809t · Cited by 509
Bifunctional Magnetic Silica Nanoparticles for Highly Efficient Human Stem Cell Labeling
Lu, C.-W., Hung, Y., Hsiao, J.-K., Yao, M., Chung, T.-H., Lin, Y.-S., Wu, S.-H., Hsu, S.-C., Liu, H.-M., Mou, C.-Y., et al. (2007) · Nano Letters · doi:10.1021/nl0624263 · Cited by 490
Mesoporous Silica Nanospheres as Highly Efficient MRI Contrast Agents
Taylor, K. M. L., Kim, J. S., Rieter, W. J., An, H., Lin, W., & Lin, W. (2008) · Journal of the American Chemical Society · doi:10.1021/ja710193c · Cited by 458
Lin, Y.-S., & Haynes, C. L. (2009) · Chemistry of Materials · doi:10.1021/cm901259n · Cited by 364
Liu, T., Li, L., Teng, X., Huang, X., Liu, H., Chen, D., Ren, J., He, J., & Tang, F. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.10.035 · Cited by 357
Multifunctional Composite Nanoparticles: Magnetic, Luminescent, and Mesoporous
Lin, Y.-S., Wu, S.-H., Hung, Y., Chou, Y.-H., Chang, C., Lin, M.-L., Tsai, C.-P., & Mou, C.-Y. (2006) · Chemistry of Materials · doi:10.1021/cm061976z · Cited by 320
Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles
Souris, J. S., Lee, C.-H., Cheng, S.-H., Chen, C.-T., Yang, C.-S., Ho, J.-A. A., Mou, C.-Y., & Lo, L.-W. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.048 · Cited by 320
Lee, C., Cheng, S., Wang, Y., Chen, Y., Chen, N., Souris, J., Chen, C., Mou, C., Yang, C., & Lo, L. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200800753 · Cited by 300
Mellaerts, R., Mols, R., Jammaer, J. A. G., Aerts, C. A., Annaert, P., Van Humbeeck, J., Van den Mooter, G., Augustijns, P., & Martens, J. A. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.11.006 · Cited by 244
Cauda, V., Schlossbauer, A., & Bein, T. (2010) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2009.11.015 · Cited by 241
Lu, J., Li, Z., Zink, J. I., & Tamanoi, F. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.06.002 · Cited by 224
Therapeutic Nanoparticles to Combat Cancer Drug Resistance
Hu, C.-M., & Zhang, L. (2009) · Current Drug Metabolism · doi:10.2174/138920009790274540 · Cited by 223
Mamaeva, V., Rosenholm, J. M., Bate-Eya, L. T., Bergman, L., Peuhu, E., Duchanoy, A., Fortelius, L. E., Landor, S., Toivola, D. M., Lindén, M., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.105 · Cited by 220
Self-citationWu, S., Lin, Y., Hung, Y., Chou, Y., Hsu, Y., Chang, C., & Mou, C. (2008) · ChemBioChem · doi:10.1002/cbic.200700509 · Cited by 209
Degradable, antibacterial silver exchanged mesoporous silica spheres for hemorrhage control
Dai, C., Yuan, Y., Liu, C., Wei, J., Hong, H., Li, X., & Pan, X. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.052 · Cited by 209
Hsiao, J., Tsai, C., Chung, T., Hung, Y., Yao, M., Liu, H., Mou, C., Yang, C., Chen, Y., & Huang, D. (2008) · Small · doi:10.1002/smll.200701316 · Cited by 208
The chemistry of silica and its potential health benefits.
Martin, K. R. (2007) · PubMed · Cited by 186
Drug delivery from ordered mesoporous matrices
Manzano, M., Colilla, M., & Vallet-Regí, M. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903304024 · Cited by 186
Lee, S., Yun, H.-S., & Kim, S.-H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.042 · Cited by 182
Advances in Nano Drugs for Cancer Chemotherapy
Ali, I., Rahisuddin, R., Salim, K., Rather, M. A., Wani, W. A., & Haque, A. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911794328493 · Cited by 158
Bone-regenerative bioceramic implants with drug and protein controlled delivery capability
Vallet‐Regí, M., Balas, F., Colilla, M., & Manzano, M. (2007) · Progress in Solid State Chemistry · doi:10.1016/j.progsolidstchem.2007.10.002 · Cited by 152
Huang, I., Sun, S.-P., Cheng, S., Lee, C., Wu, C., Yang, C., Lo, L., & Lai, Y. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0884 · Cited by 119
Mesoporous Silica Nanoparticles Inhibit Cellular Respiration
Tao, Z., Morrow, M. P., Asefa, T., et al. (2008) · Nano Letters · doi:10.1021/nl080250u · Cited by 113
Huang, X., Zhuang, J., Teng, X., Li, L., Chen, D., Yan, X., & Tang, F. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.055 · Cited by 112
Wang, T., Chai, F., Fu, Q., Zhang, L., Liu, H., Li, L., Liao, Y., Su, Z., Wang, C., Duan, B., et al. (2011) · Journal of Materials Chemistry · doi:10.1039/c0jm04115g · Cited by 107
Models of structure, dynamics and reactivity of bioglasses: a review
Tilocca, A. (2010) · Journal of Materials Chemistry · doi:10.1039/c0jm01081b · Cited by 102
Mesoporous materials as controlled drug delivery formulations
Santos, H. A., Salonen, J., Bimbo, L. M., Lehto, V., Peltonen, L., & Hirvonen, J. J. (2011) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(11)50016-4 · Cited by 96
Silica Materials in Drug Delivery Applications
Simović, S., Eskandar, N. G., Sinn, A. M., Lošić, D., & Prestidge, C. A. (2011) · Current Drug Discovery Technologies · doi:10.2174/157016311796799026 · Cited by 84
Mortera, R., Fiorilli, S., Garrone, E., Verné, E., & Onida, B. (2009) · Chemical Engineering Journal · doi:10.1016/j.cej.2009.10.018 · Cited by 62
López, T., Basaldella, E. I., Ojeda, M. L., Manjarrez-Marmolejo, J., & Alexander‐Katz, R. (2006) · Optical Materials · doi:10.1016/j.optmat.2006.03.017 · Cited by 54
Pathotropic nanoparticles for cancer gene therapy Rexin-G™ IV: Three-year clinical experience
Gordon, E. M., Lopez, F., Cornelio, G. H., Lorenzo, C., Levy, J. P., Reed, R. A., Liu, L., Bruckner, H. W., & Hall, F. L. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.5.1053 · Cited by 41
Shamsi, M. A., Alsamri, M. T., Al‐Salam, S., Conca, W., Shaban, S. F., Benedict, S., Tariq, S., Biradar, A. V., Penefsky, H. S., Asefa, T., et al. (2010) · Chemical Research in Toxicology · doi:10.1021/tx100245j · Cited by 37
Hillegass, J., Blumen, S. R., Cheng, K., MacPherson, M. B., Alexeeva, V., Lathrop, S. A., Beuschel, S. L., Steinbacher, J. L., Butnor, K. J., Ramos‐Niño, M. E., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25666 · Cited by 34
Gd‐Labeled Microparticles in MRI: In vivo Imaging of Microparticles After Intraperitoneal Injection
Steinbacher, J. L., Lathrop, S. A., Cheng, K., Hillegass, J., Butnor, K. J., Kauppinen, R. A., Mossman, B. T., & Landry, C. C. (2010) · Small · doi:10.1002/smll.201001447 · Cited by 29
Current Major Cancer Targets for Nanoparticle Systems
Wesselinova, D. W. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911794328484 · Cited by 22
Cited by
Multifunctional Mesoporous Silica Nanoparticles as a Universal Platform for Drug Delivery
Argyo, C., Weiss, V., Bräuchle, C., & Bein, T. (2014) · Chemistry of Materials · doi:10.1021/cm402592t · Cited by 903
Croissant, J. G., Fatieiev, Y., & Khashab, N. M. (2017) · Advanced Materials · doi:10.1002/adma.201604634 · Cited by 782
Chen, Y., Chen, H., & Shi, J. (2013) · Advanced Materials · doi:10.1002/adma.201205292 · Cited by 724
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
Phillips, E., Penate-Medina, O., Zanzonico, P. B., Carvajal, R. D., Mohan, P., Ye, Y., Humm, J., Gönen, M., Kalaigian, H., Schöder, H., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009524 · Cited by 712
Croissant, J. G., Fatieiev, Y., Almalik, A., & Khashab, N. M. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700831 · Cited by 594
Metadata
- Authors
- Rosenholm, J. M., Mamaeva, V., Sahlgren, C., & Lindén, M.
- Venue
- Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2011-12-22
- Volume
- 7
- Issue
- 1
- Pages
- 111-120
- ISSN
- 1743-5889 (ISSN-L)
- 1748-6963
- OpenAlex
- W1982426647
- Cited by
- 263
- References
- 53
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.